Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-02 | Gerard Michel was appointed to our Board in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries. Prior to joining the Company as its Chief Executive Officer on October 1, 2020. Additional information concerning Gerard Michel, one of our Directors and our Chief Executive Officer, is provided under Information About Our Executive Officers. |
| 2021-04-07 | Gerard Michel was appointed as a director of the Company and its Chief Executive Officer in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. The following table sets forth the total compensation awarded to, earned by or paid to our named executive officers during the fiscal years ending December 31, 2020 and December 31, 2019. Gerard Michel Chief Executive Officer 2020 Salary: $112,500 Bonus: — Options Awards: $5,629,000 All Other Compensation: $19,500 Total: $5,761,000. |
| 2022-04-04 | Gerard Michel was appointed as a director of the Company and its Chief Executive Officer in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. |
| 2023-05-01 | Gerard Michel was appointed as a director of the Company and its Chief Executive Officer in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. The proxy statement does not list any committee memberships or director compensation for Mr. Michel. |
| 2024-04-12 | Gerard Michel was appointed as a director of the Company and its Chief Executive Officer in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. ... Gerard Michel, our Chief Executive Officer and Director, participated in the offering and purchased 62,814 shares at a purchase price of approximately $250,000. ... The following table sets forth the total compensation awarded to, earned by or paid to our named executive officers during the fiscal years ending December 31, 2023 and December 31, 2022. ... Gerard Michel, Chief Executive Officer 2023 538,078 189,888 1,792,348 0 2,520,314 |
| 2025-04-01 | Gerard Michel was appointed as a director of the Company and its CEO in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. We believe that the Board is greatly enhanced by Mr. Michel’s decades of experience in the pharmaceutical and medical technology industries, his strong leadership skills and his in-depth understanding of the Company and its goals from his experience as our CEO. |
Data sourced from SEC filings. Last updated: 2025-12-06